Menactra
Menactra Products are primarily used for
Meningococcal disease, Diphtheria
About Menactra Products
Uses of Meningococcal Vaccine (Group A, C, Y & W-135)
Meningococcal Vaccine (Group A, C, Y & W-135) is used to prevent meningococcal disease.
Meningococcal Vaccine (Group A, C, Y & W-135) side effects
Common
Headache, Injection site pain, Injection site redness, Injection site induration (hardening of a normally soft tissue or organ), Irritability, Sleepiness, General discomfort, Muscle pain, Nausea.
How Menactra Products work
Meningococcal Vaccine (Group A, C, Y & W-135) is a vaccine which helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.
Diphtheria Toxoid side effects
Common
Neurological disturbances, Pain, Fever, Flushing (sense of warmth in the face, ears, neck and trunk), Decreased blood pressure, Erythema (skin redness), Slow heart rate, Tenderness, Hives.
How Menactra Products work
Diphtheria Toxoid is a vaccine.It helps develop immunity by initiating a mild infection. This type of infection does not cause illness, but it does stimulate the body's immune system to produce antibodies to protect against any future infections.
Patient Concerns about Menactra
Frequently asked questions about Menactra Products
Frequently asked questions about Meningococcal Vaccine (Group A, C, Y & W-135)
Q. What is Meningococcal Vaccine (Group A, C, Y & W-135)?
Meningococcal Vaccine (Group A, C, Y & W-135) is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Meningococcal Vaccine (Group A, C, Y & W-135) is approved for use in persons aged 2 months through 55 years.
Q. Who should not take Meningococcal Vaccine (Group A, C, Y & W-135)?
Meningococcal Vaccine (Group A, C, Y & W-135) should not be given to patients with known allergy to any other ingredients of this medicine, or any other similar medicines in the past. Signs of an allergic reaction may include an itchy skin rash, shortness of breath and swelling of the face or tongue. If you have had an allergic reaction to any medicine earlier, inform your doctor about it.
Q. Is a booster dose of Meningococcal Vaccine (Group A, C, Y & W-135) needed?
Yes, a single booster dose of Meningococcal Vaccine (Group A, C, Y & W-135) may be administered to individuals aged 15 through 55 years who may be at a continued risk of getting meningococcal disease, if at least 4 years have passed since a prior dose of it was given. If you have any doubts, consult your doctor.
Q. How is Meningococcal Vaccine (Group A, C, Y & W-135) given?
Meningococcal Vaccine (Group A, C, Y & W-135) is given by a trained healthcare professional or a doctor only and should not be self-administered. Usually, it is given into the muscle of your upper arm, but it may also be given in the thigh muscle in children. Follow your doctor’s instructions carefully to get maximum benefit from Meningococcal Vaccine (Group A, C, Y & W-135).
Q. Can Meningococcal Vaccine (Group A, C, Y & W-135) cause meningococcal disease?
No. Meningococcal Vaccine (Group A, C, Y & W-135) will not cause meningococcal disease. It just helps your body in producing antibodies against it, so that your body can fight the infection if you are exposed to it in future.
Frequently asked questions about Diphtheria Toxoid
Q. Is diphtheria toxin an endotoxin?
No, diphtheria toxin is an exotoxin and not an endotoxin
Q. Is diphtheria toxin a protein?
Yes, diphtheria toxin is an extracellular protein of the bacteria Corynebacterium diphtheriae.
Products for Menactra
Menactra Vaccine
vial of 1 Solution for Injection
MRP
₹5700